Affiliation:
1. Department of Analytical Biochemistry, Institute of Food Technology and Nutrition, College of Natural Sciences, Rzeszow University, Zelwerowicza Street 4, 35-601 Rzeszów, Poland
2. Department of Bioenergetics, Food Analysis and Microbiology, College of Natural Sciences, Rzeszow University, Zelwerowicza Street 4, 35-601 Rzeszów, Poland
Abstract
Due to the progressive aging of the society, the prevalence and socioeconomic burden of neurodegenerative diseases are predicted to rise. The most common neurodegenerative disorders nowadays, such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis, can be classified as proteinopathies. They can be either synucleinopathies, amyloidopathies, tauopathies, or TDP-43-related proteinopathies; thus, nanoparticles with a potential ability to inhibit pathological protein aggregation and/or degrade already existing aggregates can be a promising approach in the treatment of neurodegenerative diseases. As it turns out, nanoparticles can be a double-edged sword; they can either promote or inhibit protein aggregation, depending on coating, shape, size, surface charge, and concentration. In this review, we aim to emphasize the need of a breakthrough in the treatment of neurodegenerative disorders and draw attention to nanomaterials, as they can also serve as a diagnostic tool for protein aggregates or can be used in a high-throughput screening for novel antiaggregative compounds.
Subject
Cell Biology,Aging,General Medicine,Biochemistry
Reference82 articles.
1. Global health and ageing;World Health Organization,2011
2. Neurodegenerative diseases;H. Checkoway;IARC Scientific Publications,2011
3. Epidemiology of Parkinson’s disease
4. The burden of Parkinson's disease: a worldwide perspective
5. The epidemiology of amyotrophic lateral sclerosis
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献